Dr. Jason Kim and Dr. Steven Weissbart from the Women's Pelvic Health and Continence Center at Stony Brook University Hospital have conducted one of the first Glean Urodynamics procedures in the United States, marking a pioneering step on the East Coast. This procedure utilized Bright Uro's ambulatory urodynamic system, which offers an innovative approach to monitoring bladder function.
The new technology is designed to improve the evaluation of bladder dysfunction for approximately 17 million Americans experiencing daily bladder control issues. Unlike traditional methods that require catheterization and clinical observation, this system allows real-time data collection in everyday settings, enhancing diagnostic accuracy and patient comfort without invasive procedures.
Dr. Jason Kim, who is also an Associate Professor of Urology and Director of the Women's Pelvic Health and Continence Center at SBUH, was the national principal investigator for the FDA-approved trial of this system. The trial results were published in the Journal of Endourology.
"We are proud to be at the forefront of urologic innovation," said Dr. Kim. "This new technology marks a major step forward in patient-centered care by providing a more physiologic, less invasive approach to urodynamic testing."
Stony Brook University Hospital is recognized as Long Island’s leading academic health center with various specialized institutes including its Heart Institute, Cancer Center, Children’s Hospital, Neurosciences Institute, among others.